Relistor (Salix Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Relistor drug offered from Salix Pharmaceuticals, Inc.. This Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Salix Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Methylnaltrexone bromide |
SUBSTANCE NAME: | METHYLNALTREXONE BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-04-24 |
END MARKETING DATE: | 0000-00-00 |
Relistor HUMAN PRESCRIPTION DRUG Details:
Item Description | Relistor from Salix Pharmaceuticals, Inc. |
LABELER NAME: | Salix Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12(mg/.6mL) |
START MARKETING DATE: | 2008-04-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65649-551_4d9900e0-9c7d-4551-b7f4-d047b92435c8 |
PRODUCT NDC: | 65649-551 |
APPLICATION NUMBER: | NDA021964 |
Other METHYLNALTREXONE BROMIDE Pharmaceutical Manufacturers / Labelers: